Advertisement

Topics

Popular Biotech News, Healthcare News and Pharma News

03:58 EDT 27th May 2017 | BioPortfolio

Futura Medical Plc FUM Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10052017] Prices from USD $250

SummaryFutura Medical Plc Futura Medical is a pharmaceutical company. It carries out the research and development of novel products for the consumer healthcare market specializing in sexual healthcare and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal drug delivery system, DermaSys. It has products in the development pipeline for sexual h...

Extendicare Inc EXE Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryExtendicare Inc Extendicare, formerly Crownx Inc. is a healthcare service provider that provides longterm care services with a wide range of senior care centers. The centers provide services such as short stay care, convalescent care, home health care, group purchasing, assisted living, longterm care, workplace health and wellness and complex continuing care. It offers home health care thro...

Parexel International Corp PRXL Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 17052017] Prices from USD $250

SummaryParexel International Corp Parexel is a biopharmaceutical outsourcing services company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, ...

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

Metabolic reprogramming by oncogenic signals promotes cancer initiation and progression. The oncogene KRAS and tumour suppressor STK11, which encodes the kinase LKB1, regulate metabolism and are frequently mutated in non-small-cell lung cancer (NSCLC). Concurrent occurrence of oncogenic KRAS and loss of LKB1 (KL) in cells specifies aggressive oncological behaviour. Here we show that human KL cells...

Ocular Therapeutix Inc OCUL Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 12052017] Prices from USD $250

SummaryOcular Therapeutix Inc Ocular formerly ITherapeutix, Inc., is a biopharmaceutical company that develops therapies for diseases using hydrogel platform technology. The company's products include DEXTENZA, sustained release travoprost and posterior segment injections. Its hydrogel technology uses polyethylene glycol to create ophthalmic sustained drug delivery systems. Ocular's hydrogel provi...

Humana Inc HUM Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10052017] Prices from USD $250

SummaryHumana Inc Humana is a health and wellbeing company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company's Medicare products and services include Medicare Advantage plan, prescription drug plan, Medicare supplement insurance plans, ...

OPKO Health Inc OPK Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 17052017] Prices from USD $250

SummaryOPKO Health Inc OPKO, formerly eXegenics Inc, is a biopharmaceutical and diagnostic company. It discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company's product portfolio includes pointofcare tests, laboratory developed tests LDTs, molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers products and va...

GE Healthcare launches Capto™ Blue affinity chromatography medium

24th August 2011:  GE Healthcare’s Capto Blue affinity chromatography medium is for the capture of human serum albumin (HSA), as well as purification of HSA fusion proteins, blood coagulation factors, enzymes, and recombinant proteins at laboratory and process scales. Developed from Blue Sepharose™ 6 Fast Flow, Capto Blue medium is more chemically stable and has a more rigid ...

KSQ Therapeutics

KSQ Therapeutics, Inc. is a functional genomics company. We have developed a novel genetics tool that allows us to screen the human genome to uncover information on specific diseases. We utilize this knowledge to target drugs for treatment of these diseases.

Espero Pharmaceuticals Selects DDB Health and Alamo Pharma Services as Partners for the Launch of GONITRO™ (Nitroglycerin) Sublingual Powder

Wednesday, August 31st 2016 at 1:00pm UTC Available in Single Dose Packets, GONITROTM is Approved For Acute Relief of an Angina Pectoris Attack Due to Coronary Artery Disease JACKSONVILLE, Fla.–(BUSINESS WIRE)– Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that DDB Health, an Omnicom Health Group company, as its agency of record …...

Earlens selects iBASEt for 3D printing of hearing Aid

iBASEt announced that Earlens, a medical technology company that created a novel hearing aid, will implement iBASEt's Solumina software as its manufacturing execution system (MES).

VivaGel® BV granted QIDP and Fast Track designation by US FDA

Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) today announced it has been granted Qualified Infectious Disease Product (QIDP) and Fast Track designation for VivaGel® BV by the US Food and Drug Administration (FDA). QIDP and Fast Track designations were granted independently for both the VivaGel® BV treatment and prevention indications for ...

Ostiio wants to improve quality of life for kids with craniofacial defects

Ostiio has developed a distractor device used in distraction osteogenesis to increase bone for children with craniofacial defects.

Researchers create Blueprint for Transparency at FDA to advance development of effective new products

As the new administration considers the future direction of the Food and Drug Administration, a group of leading researchers has created a Blueprint for Transparency at the agency to advance the development of safe and effective new products.

What’s Behind the Headlines? Separating Health and Nutrition Facts from Fiction

By: Beth Winthrop SOURCE: Sodexo, Inc. DESCRIPTION:In today’s media-saturated world, information about health and nutrition is everywhere. But while we have access to more reliable information about nutrition than ever, there are also many scientifically questionable or even false claims presented as fact. It’s becoming increasingly difficult to sort out truths from falsehoods. One such quest...

Ansell Launches VivaGel® Condom in Canada

Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) is pleased to announce the VivaGel® condom has been launched in Canada by Ansell (ASX:ANN) under the LifeStyles® Dual Protect™ brand. These condoms carry the VivaGel® brand and Starpharma will receive royalties based on sales. Ansell is a global leader in protection solutions and the makers of ...

Harpoon Therapeutics Appoints Che-Leung Law, Ph.D., as Vice President, Translational Medicine

Company Adds Ramy Ibrahim, M.D., to Scientific Advisory Board Harpoon Therapeutics, Inc., a biotechnology company developing novel T-cell and other immune-cell recruiting biologic therapies for the treatment of cancer and immunologic disorders, today announced the appointment of Che-Leung Law, Ph.D., to vice president, translational medicine. ...

Hamilton Robotics Collaborates with Illumina in the European Union for Streamlined Noninvasive Prenatal Testing Solution

Automated Whole-Genome Sequencing Approach Provides Confidence in Results with Increased Sample Throughput and Decreased Turnaround Time Hamilton Robotics continues to strengthen their ongoing partnership with Illumina, Inc. through the collaborative development of the VeriSeq™ NIPT Solution for high-throughput noninvasive prenatal testing (NIPT). This automated, next-generation sequencing (...

Consort Medical plc CSRT Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 24042017] Prices from USD $250

SummaryConsort Medical plc Consort Medical is a global contract development and manufacturing organization CDMO with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and pointofcare POC diagnostics. It offers metered dose inhalers, dry powder devices, actuators, dose counters, disposable autoinjec...

21st Century Oncology Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 24042017] Prices from USD $250

Summary21st Century Oncology Inc 21st Century Oncology, formerly Radiation Therapy services, Inc. is a subsidiary of 21st Century Oncology Holdings, Inc. It is a provider of integrated cancer care services ICC to patients suffering from various cancer indications. It operates an integrated network of cancer treatment centers and affiliated physicians who are specialized in the fields of radiation ...

DAWN™ Trial Results Demonstrate a 73% Reduction in Disability in Stroke Patients Treated up to 24 Hours

Results from the DAWN Trial were presented today at the European Stroke Organisation Conference, providing compelling evidence that more patients suffering ischemic stroke may benefit from endovascular treatment. Kalamazoo, Michigan (PRWEB) May 16, 2017 Results from the DAWN Trial were presented today at the European Stroke Organisation Conference (ESOC), providing compelling evidence that more p...

2017 Alzheimer’s Disease International-Home Instead Family Carer of the Year: Simone Martini

Italian family carer and advocate presented award for his efforts to raise awareness for and change stigma of the disease through AL(z)–CINEMA initiative KYOTO, Japan (PRWEB) May 17, 2017 Simone Martini of Milan, Italy, was recently named the 2017 recipient of the ADI-Home Instead Family Carer of the Year Award. He is being recognized for the meaningful and positive impact he has made on the li...

Ampio Pharmaceuticals Inc AMPE Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryAmpio Pharmaceuticals Inc Ampio formerly Chay Enterprises, Inc. is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company offers products for the treatment of osteoarthritis of the knee and for the treatment of diabetic macular edema. Its products include low molecular weight fraction of human serum albumin and ultralow ...

Peripheral Arterial Disease PAD/ Peripheral Vascular Disease PVD Pipeline Review, H1 2017 [Updated: 16052017] Prices from USD $2000

Peripheral Arterial Disease PAD/ Peripheral Vascular Disease PVD Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Arterial Disease PAD Peripheral Vascular Disease PVD Pipeline Review, H1 2017, provides an overview of the Peripheral Arterial Disease PAD Peripheral Vascular Disease PVD Cardiovascular pipeline landscape.Pe...

Orchid Pharma Ltd ORCHIDPHAR Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryOrchid Pharma Ltd Orchid is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, antidiabetic products, nutritional supplements, and various other products. It offers API such as cephalosporinsorals, cephalosporinsinjectibles, veterina...

SIGA Technologies Inc SIGA Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummarySIGA Technologies Inc SIGA, a subsidiary of MacAndrews Forbes Holdings Inc, is a pharmaceutical company that develops pharmaceutical solutions for serious unmet medical needs and biothreat. The company provides tecovirimat also known as ST246, an orally administered antiviral drug that targets orthopoxviruse. Its product is used to treat individuals with latestage lesional smallpox and dis...

BrainStorm Cell Therapeutics Inc BCLI Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryBrainStorm Cell Therapeutics Inc BrainStorm Cell Therapeutics is a biotechnology company that develops autologous stem cell therapies for debilitating neurodegenerative diseases. It provides therapies for multiple sclerosis, amyotrophic lateral sclerosis, and Parkinson's disease. The company develops NurOwn technology for the propagation and differentiation of autologous mesenchymal stem ce...

Calmare Therapeutics Inc CTTC Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryCalmare Therapeutics Inc CTI, formerly known as Competitive Technologies Inc is a medical device company that offers pain mitigation and wound care technologies. The company provides nonpharmacological, nonaddictive and noninvasive solution to chronic pain sufferers in an outpatient treatment setting. It offers Calmare a pain therapy device; devices, consumables and related hardware. CTI pr...

Intellia Therapeutics Inc NTLA Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryIntellia Therapeutics Inc Intellia Therapeutics is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 system. The company develops in vivo programs for treating liver diseases such as transthyretin amyloidosis, alpha1 antitrypsin deficiency, hepatitis B virus and primary hyperoxaluria. It also develops ex vivo programs for chimeric antigen receptor T ...

Catalyst Biosciences Inc CBIO Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryCatalyst Biosciences Inc Catalyst, formerly Targacept, Inc., is a biopharmaceutical company that offers medicine. The company discovers and develops next generation biopharmaceuticals based on engineered human proteases platform technology. It concentrates on the development of products for hemostasis and anticomplement. Catalyst's hemostasis product portfolio includes FVlla, FIX, and FXa; ...

Cytodyn Inc CYDY Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryCytodyn Inc Cytodyn is a biotechnology company which offers research and development of therapeutic monoclonal antibodies for the treatment of HIV infections. The company is focused on clinical development and potential commercialization of humanized monoclonal antibodies. It offers product such as PRO 140, Cytofeline and Cytolin. Cytodyn's PRO 140 is under phase III clinical development wh...

Health Discovery Corp HDVY Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryHealth Discovery Corp HDC is a biotechnology company that offers medicine and biomarker discovery services. The company's products comprise support vector machine, recursive feature elimination and fractal genomic modeling. It offers SVM technology that is an artificial intelligence applicable in medical diagnosis, bioinformatics, classifying DNA sequences, detecting credit card fraud, stoc...

ERT Introduces Advanced Solution to Capture, Measure and Analyze Lung Clearance Index (LCI)

Solution provides greater data granularity to measure disease progression in respiratory trials where standard spirometry is insufficient PHILADELPHIA (PRWEB) May 22, 2017 ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index d...

Anthem Blue Cross Creates New Enablement Platform to Connect Patient Information Across All Vivity Partner Hospitals

New system gives insight into a patient’s medical history and the increased ability to coordinate care across all Vivity partners Anthem Blue Cross (Anthem) today announced the launch of a new population health system connecting patient information among all seven original Vivity hospital systems. These connections give providers access to robust inf...

Cleveland BioLabs Inc CBLI Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryCleveland BioLabs Inc Cleveland is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company's product includes entolimod, a recombinant protein which acts as an agonist of tolllike receptor that finds application in radiation mitigation, oncology immunotherapy, and vaccines...

USMC, Indiana, Texas and Oklahoma Making Hyperbaric Oxygen Therapy (HBOT) Available to Service Members with TBI/PTSD/Concussion

Data from over 2,300 subjects, legislative breakthroughs at the state level, and some forward thinking by the US Marines is allowing access to an alternative treatment for "invisible wounds." HBOT research out of the state of Washington also shows promise for alleviating withdrawal symptoms from drug addiction. Washington, DC (PRWEB) May 23, 2017 Camp Lejeune, US Marine Corps, with the ...

Shanghai Fosun Pharmaceutical Group Co Ltd 600196 Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryShanghai Fosun Pharmaceutical Group Co Ltd Fosun Pharma, a subsidiary of Shanghai Fosun High Technology Group Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company's pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, antiinfection, ant...

Soleo Health Advocates for Thousands of Home Infusion Therapy Patients Affected by 21st Century Cures Act

Company Authors White Paper Outlining Impact on Vulnerable Patients; Joins Industry Coalition and Garners Support from Physicians and Patients in Quest to Reach Policymakers Soleo Health, a national provider of specialty home and alternate-site infusion services, announced today it is aggressively advocating for thousands of home infusion therap...

Eppendorf 5415C Benchtop Centrifuge w/ Rotor

$91.00 (5 Bids)End Date: Tuesday May-23-2017 14:45:34 PDTBid now | Add to watch list Biotech365 : Eppendorf 5415C Benchtop Centrifuge w/ Rotor BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic software … Continue reading → Cet article Eppendorf 5415C Benchtop Centrifuge w/ Rotor est apparu en premier sur Biotech 365.

Marksans Pharma Ltd MARKSANS Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 10052017] Prices from USD $250

SummaryMarksans Pharma Ltd Marksans Pharma is a pharmaceutical company that develops, manufactures, and sells branded formulations and generic products. The company provides contract research and manufacturing services CRAMS to various pharmaceutical companies. Its focus therapy segments comprise antibiotics, antidiabetic, antiinflammatory, cardiovascular, gynaecology and pain management among oth...

Peregrine Pharmaceuticals Inc PPHM Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryPeregrine Pharmaceuticals Inc Peregrine is a biopharmaceutical company that develops and manufactures monoclonal antibodies for the treatment and diagnosis of cancer. The company's products include Bavituximab, PGN650 and Cotara. Its Bavituximab is a monoclonal antibody that binds to a basic component of the cell structure called a phospholipid. Peregrine's Cotara is for Phase III clinical ...

Just half a glass of wine a day may increase breast cancer risk

"Just half a glass of wine a day ups the risk of breast cancer by nine per cent, experts warn," The Sun reports. A major report looking at global evidence found that drinking just 10g of alcohol a day – 1.25 units – was linked to an increased risk of breast cancer. The report was produced by the World Cancer Research Fund which reviews the global evidence on the link between diet, we...

Exelixis Inc EXEL Financial and Strategic SWOT Analysis Review [Updated: 09052017] Prices from USD $125

Exelixis Inc EXEL Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your bus...

CVS’ Merlo talks AHCA, opioid crisis on WBUR

CVS Health president and CEO Larry Merlo was the guest on Boston’s WBUR radio station’s “Here & Now” Tuesday, speaking with host Jeremy Hobson about such topics as tax reform, Amazon’s potential entry into pharmacy and the ongoing question of what changes will come to health care as the Senate considers the American Health Care Act. “I think there are elem...

American Bio Medica Corp ABMC Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryAmerican Bio Medica Corp ABMC is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company's products include Rapid TOX, a point of collection testing POCT product that detects 110 drugs of abuse DOA in a urine specimen; Rapid One, a test cassette which is designed to detect a single DOA in a urine specimen; Rapid Drug Screen, detects 2 to 10 DOA in ...

Tesaro Inc TSRO Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 17052017] Prices from USD $250

SummaryTesaro Inc Tesaro is an oncologyfocused biopharmaceutical company that focuses on developing inlicensed, oncologyrelated product candidates, comprising rolapitant, niraparib, and the product candidates under its immunooncology platform. VARUBI, the company's first commercial product is approved for use in combination with other antiemetic agents in adults for the prevention of delayed nause...

OncoMed Pharmaceuticals Inc OMED Financial and Strategic SWOT Analysis Review [Updated: 15052017] Prices from USD $300

SummaryOncoMed Pharmaceuticals Inc OncoMed focuses on the discovery and development of monoclonal antibody therapeutics which targets cancer stem cells. The company's clinical stage pipeline product candidate includes demcizumab, vantictumab, tarextumab, ipafricept, antiRSPO3, brontictuzumab and antiDDL4/VEGF. OncoMed's expertise spans oncology research, drug discovery, clinical development, regul...

2026 Forecast: Growth Hormone Deficiency Market to Surpass $2B

NewsGrowth hormone deficiency market to grow steadily, surpassing $2 billion by 2026, says GlobalData.Contributed Author: GlobalDataTopics: Global

MethicillinResistant Staphylococcus aureus MRSA Infections Pipeline Review, H1 2017 [Updated: 23052017] Prices from USD $2000

MethicillinResistant Staphylococcus aureus MRSA Infections Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide MethicillinResistant Staphylococcus aureus MRSA Infections Pipeline Review, H1 2017, provides an overview of the MethicillinResistant Staphylococcus aureus MRSA Infections Infectious Disease pipeline landscape.MRSA infection...

Quick Search
Advertisement